-

Worldwide Vector Control Industry to 2027 - by Type, Method of Control, End-user and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Vector Control Market to 2027" report has been added to ResearchAndMarkets.com's offering.

Vector control is the method which is used to limit or eradiate the birds, mammals, insects, or other arthropods that are collectively called vectors and are responsible for transmitting disease pathogens. Mosquito control is the type of vector control which is done by using various strategies. Theses vectors are the cause of spreading various diseases such as fever, dengue, West Nile virus, and Zika Virus.

Companies Mentioned

  • Arrow Exterminators Inc
  • Bell Laboratories Inc.
  • The Terminix International Company Lp
  • Rollins Inc.
  • Ecolab
  • FMC Corporation
  • Rentokil Initial PLC.
  • Syngenta AG
  • Bayer AG
  • BASF SE

Market Drivers

Increase in incidences of vector borne diseases is the key driving factor which is expected to boost the global vector control market growth. Further, growing awareness about vector control methods among well known organizations will have the positive impact on global vector control market growth. Moreover, increase in number of surgical procedures, and increase in incidences of chronic diseases which are expected to boost the global vector control market growth. Also, continuous technological developments which are expected to drive the global vector control market growth during this forecast period.

Market Restraints

However, long approval procedure and lack of uniform procedures for testing are the restraining factors which are expected to hamper the global vector control market growth.

Market Segmentation

Global Vector Control Market is segmented into vector type such as Rodents, Insects, and Others, by method of control such as Biological Control Methods, Chemical Methods (Larvicides, Pyrethroids, Organophosphates, and Others), and Physical & Mechanical Control Methods. Further, Global Vector Control Market is segmented into end user such as Commercial & Industrial, and Residential.

Also, Global Vector Control Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Global Vector Control Market Outlook

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.3 Porters Five Force Model

4.4 Value Chain Analysis

5 Global Vector Control Market, By Type

5.1 Y-o-Y Growth Comparison, By Type

5.2 Global Vector Control Market Share Analysis, By Type

5.3 Global Vector Control Market Size and Forecast, By Type

5.3.1 Rodents

5.3.2 Insects

5.3.3 Others

6 Global Vector Control Market, By Method of Control

6.1 Y-o-Y Growth Comparison, By Method of Control

6.2 Global Vector Control Market Share Analysis, By Method of Control

6.3 Global Vector Control Market Size and Forecast, By Method of Control

6.3.1 Biological Control Methods

6.3.2 Chemical Methods

6.3.2.1 Larvicides

6.3.2.2 Pyrethroids

6.3.2.3 Organophosphates

6.3.2.4 Others

6.3.3 Physical & Mechanical Control Methods

7 Global Vector Control Market, By End User

7.1 Y-o-Y Growth Comparison, By End User

7.2 Global Vector Control Market Share Analysis, By End User

7.3 Global Vector Control Market Size and Forecast, By End User

7.3.1 Commercial & Industrial

7.3.2 Residential

8 Global Vector Control Market, By Region

8.1 Global Vector Control Market Share Analysis, By Region

8.2 Global Vector Control Market Share Analysis, By Region

8.3 Global Vector Control Market Size and Forecast, By Region

9 North America Vector Control Market Analysis and Forecast (2017 - 2027)

10 Europe Vector Control Market Analysis and Forecast (2017 - 2027)

11 Asia Pacific Vector Control Market Analysis and Forecast (2017 - 2027)

12 Latin America Vector Control Market Analysis and Forecast (2017 - 2027)

13 Middle East Vector Control Market Analysis and Forecast (2017 - 2027)

14 Competitive Analysis

14.1 Competition Dashboard

14.2 Market share Analysis of Top Vendors

14.3 Key Development Strategies

15 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/2r4exu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and Sanofi - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Semaglutide Market is expected to expand from US$ 8.17 Billion in 2024 to US$ 17.29 Billion in 2033 at a Compound Annual Growth Rate (CAGR) of 8.68% during 2025-2033 The growth is fueled by rising awareness regarding obesity control, increasing incidence of diabetes,...

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...

Liraglutide and Semaglutide Global Strategic Business Analysis Report 2025-2030: Regulatory Pipeline for Pediatric and Adolescents With Obesity Creates Long-Term Market Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 Billion in 2024 and is projected to reach US$29.8 Billion by 2030, growing at a CAGR of 9.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Liraglutide and s...
Back to Newsroom